“…Since Christie and Kenner reported the first detection of atropisomerism in 1922 (Christie and Kenner, 1922), axial chirality was found in a lot of natural products and pharmaceutical compounds as exemplified by michellamines (Manfredi et al, 1991;Bringmann et al, 1993) and vancomycin (Nicolaou et al, 1999). Besides, many chiral ligands and catalysts, such as BINOL, BINAP, and phosphoric acids, have been developed based on axially chiral biaryl scaffolds (Miyashita et al, 1980;Akutagawa, 1995;Kumobayashi et al, 2001;Brunel, 2005;Brunel, 2007;Genet et al, 2014). It is well-known that the enantiopurities of chiral ligands and catalysts are critical to their enantiocontrol, and atropisomers of bioactive molecules always exhibit different pharmacodynamic and pharmacokinetic behavior both in vivo and in vitro (Eichelbaum and Gross, 1996;Clayden et al, 2009).…”